Literature DB >> 8887304

Menopause, fat and lean distribution in obese women.

G Panotopoulos1, J C Ruiz, J Raison, B Guy-Grand, A Basdevant.   

Abstract

OBJECTIVES: Whether menopause per se influences fat distribution independently of the effect of aging remains controversial. The lack of consistency in the menopause related changes in body fat distribution may be the result of differences in the methods for measuring fat distribution or in the characteristics of the women studied. The aim of this cross sectional study in obese women was to compare total body composition and regional fat and lean distribution, in premenopausal, perimenopausal and postmenopausal women.
METHODS: Body composition was assessed by dual energy X-ray absorptiometry (DEXA) in premenopausal (n = 26), perimenopausal (n = 24) and postmenopausal (n = 73) obese women with no intercurrent diseases.
RESULTS: It was shown that postmenopausal obese (n = 73) women had a higher proportion of total fat mass in the trunk and a lower proportion of total fat and lean mass in the femoral and leg regions than premenopausal women after adjustment for age and total fat mass. In the same analysis, perimenopausal women had a lower proportion of total fat in the leg and femoral regions and of total lean in the femoral region than premenopausal women; they had a regional body composition similar to that of postmenopausal women.
CONCLUSION: The present data indicate that in obese women, post menopause and perimenopause are associated with differences in fat and lean distribution, independently of age and total fat.

Entities:  

Mesh:

Year:  1996        PMID: 8887304     DOI: 10.1016/0378-5122(96)01119-x

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  16 in total

Review 1.  Body composition and muscle performance during menopause and hormone replacement therapy.

Authors:  S Sipilä
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

2.  Significant associations of age, menopausal status and lifestyle factors with visceral adiposity in African-American and European-American women.

Authors:  Ellen W Demerath; Nikki L Rogers; Derek Reed; Miryoung Lee; Audrey C Choh; Roger M Siervogel; Wm Cameron Chumlea; Bradford Towne; Stefan A Czerwinski
Journal:  Ann Hum Biol       Date:  2010-12-22       Impact factor: 1.533

Review 3.  Ovarian hormones and obesity.

Authors:  Brigitte Leeners; Nori Geary; Philippe N Tobler; Lori Asarian
Journal:  Hum Reprod Update       Date:  2017-05-01       Impact factor: 15.610

Review 4.  Effect of menopausal hormone therapy on components of the metabolic syndrome.

Authors:  Dragana Lovre; Sarah H Lindsey; Franck Mauvais-Jarvis
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-05-27

Review 5.  Sex differences in the physiology of eating.

Authors:  Lori Asarian; Nori Geary
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-31       Impact factor: 3.619

Review 6.  Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications.

Authors:  Franck Mauvais-Jarvis; JoAnn E Manson; John C Stevenson; Vivian A Fonseca
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

7.  The relationship between endogenous androgens and body fat distribution in early and late postmenopausal women.

Authors:  Yuankui Cao; Shaofen Zhang; Shien Zou; Xian Xia
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

8.  Greater short-term weight loss in women 20-45 versus 55-65 years of age following bariatric surgery.

Authors:  Christopher N Ochner; Julio Teixeira; Nori Geary; Lori Asarian
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

Review 9.  Associations between gender, age and waist circumference.

Authors:  J Stevens; E G Katz; R R Huxley
Journal:  Eur J Clin Nutr       Date:  2009-09-09       Impact factor: 4.016

Review 10.  Influence of menopause on diabetes and diabetes risk.

Authors:  Emily D Szmuilowicz; Cynthia A Stuenkel; Ellen W Seely
Journal:  Nat Rev Endocrinol       Date:  2009-08-18       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.